Social and medical-social stakeholders according to the stage of progress of your project
Discover the players who can contribute to your projects
Discover the sector
Discover the ecosystem players likely to be involved in your entrepreneurial journey:
- public policies for the sector, defined by the Direction générale de la cohésion sociale (DGCS) and the Délégation du numérique en santé (DNS);
- orientations and studies by the Caisse nationale de solidarité pour l'autonomie (CNSA), the Haute Autorité de santé (HAS) and the Agence nationale d'appui à la performance des établissements sanitaires et médico-sociaux (ANAP);
- news via the specialized press (HOSPIMEDIA, TICsanté, TICpharma, Gerontonews, APMnews, etc.).).
Technical development
The Agence du numérique en santé (ANS) can help you better identify the reference systems and core services of the doctrine of digital health, which your solution must integrate.
The GIE SESAM-Vitale can support you in connecting your solution to the teleservices of the Assurance-Maladie, if your innovation requires it.
You must integrate the Regulations relating to the protection of personal data (RGPD), with the help, if necessary, of the Commission nationale informatique et libertés (CNIL).
Advice and guidance
You can approach:
- the support players (consulting firms, incubators, regional economic development agencies, gas pedals, clusters, innovation centers, competitiveness clusters etc. specialized in the social and medico-social sector);
- the French Tech;
- one of the federations representing digital solution providers.
Experimentation and evaluation
After developing a first version of your solution, you can rely on various structures to test it and evaluate its acceptability, usage, impact and medico-economic benefit.
You can be supported by:
- Tiers-Lieux d'expérimentation en santé ;
- Living-Lab santé autonomie ;
- Gérontopôles.
Medical CE marking
If your solution is a medical device, you must obtain a CE mark to market it.
You can then approach the Agence nationale de sécurité du médicament et des produits de santé (ANSM), via its Guichet innovation et orientation (GIO), which can support you in your process of obtaining CE marking.
Good to know: the ANSM must authorize a clinical study involving the human person. It also designates notified bodies and carries out checks on marketed solutions.
Project-phase financing
You can:
- respond to national (e.g. Bpifrance, Banque des territoires) and regional (e.g.: Regional Health Agencies, Regional Councils and their economic development agencies, Departmental Councils);
- obtain prizes and competitions regularly launched by complementary healthcare companies, foundations and patrons ;
- contact the Direction régionale de l'économie, de l'emploi, du travail et des solidarités (DREETS) of your region, to find out about the financial support provided by the State,
- consult the search engine Aides-Territoires G_NIUS.
Financing in the marketing phase
In the marketing phase, you may be eligible for reimbursement by:
- the Direction Générale à l'Offre de Soins (DGOS)and the Haute Autorité de Santé (HAS), by applying for an innovation package;
- the Assurance-Maladie, by submitting to a double evaluation by the Agence du Numérique en Santé (ANS) and the Haute Autorité de Santé (HAS) ;
- the departments, via the Conférence des financeurs of each department in the field of autonomy and via the Maisons Départementales pour les Personnes Handicapées.
Communication
To publicize your innovation, you can in particular turn to:
- the federations representing the social and medico-social sector ;
- the scholarly societies ;
- the purchasing pools ;
- the specialized press ;
- the Tiers-Lieux d'expérimentation en santé.
Social and medical-social actors
Overview of actors in the social and medical-social sector
G_NIUS offers an overview of the key players to know in order to innovate in the social and/or medical-social sector.
The social and medico-social sector refers to activities and services aimed at promoting independence and preventing exclusion by organizing care for people who are vulnerable due to health problems, disability, dependency, or social exclusion.
On G_NIUS, you can find stakeholders classified by the type of needs you may have in your entrepreneurial journey:
To begin with, it is useful to identify the stakeholders who govern public policy and set the broad guidelines to be followed in the social and medico-social sector.
In France, social and medico-social sector policies are defined by the Directorate-General for Social Cohesion (DGCS) and the Digital Health Delegation (DNS).
The National Solidarity Fund for Autonomy (CNSA), the High Authority for Health (HAS), and the public intervention and advisory agency attached to the Ministry of Health (ANAP) define broad guidelines and publish studies.
The ANAP's specific mission is to support health and medico-social establishments and structures in improving their performance in all areas.
The regional healthcare system is organized by regional health agencies (ARS). They coordinate activities and allocate the operating budget for medical-social structures.
Certain bodies, such as the National Commission for Information Technology and Civil Liberties (CNIL) and the Digital Health Agency (ANS), are worth consulting to ensure that the technical development of your solution complies with current regulations and with the standards and core services of the digital health doctrine.
In addition, the SESAM-Vitale economic interest group (GIE) can help you connect your solution to the Health Insurance teleservices, if your project is suitable.
Whatever stage your entrepreneurial project is at, you can get in touch with stakeholders and professionals who support and/or promote start-ups, such as French Care, consulting firms, incubators, accelerators, clusters, innovation centers, competitiveness clusters, etc.
Experimentation and evaluation
During the testing phase, you can work with stakeholders to evaluate the acceptability, use, impact, and medical and economic benefits of your innovation among different audiences.
Here, Tiers-Lieux d'Expérimentation for health, health and autonomy living labs, and gerontology centers are particularly relevant and allow you to be in contact with healthcare professionals.
If your innovation meets the definition of a medical device, you are required to have CE (European Conformity) marking in order to market it.
The French National Agency for Medicines and Health Products Safety (ANSM) has set up an Innovation and Guidance Desk (GIO) for those with innovative projects or ongoing development projects, which can help you understand the steps you need to take to obtain CE marking.
If you are looking for financial support for your innovation project, you can contact the Regional Directorate for Economy, Employment, Labor, and Solidarity (DREETS) in your region to find out about the financial support available from the government.
In addition, certain organizations such as La Banque des Territoires (Bpifrance) and the Regional Health Agencies (ARS) issue calls for projects that may enable you to receive financial assistance.
There are also opportunities for one-off financial support through prizes in competitions offered by complementary health insurance providers and foundations.
Financing during the marketing phase
If you are seeking funding, you may be eligible for coverage by the Directorate General for Healthcare Provision (DGOS), the High Authority for Health (HAS), or the French national health insurance system.
In order to communicate your solution to different audiences, you can contact federations representing professionals in the social and medico-social sector, learned societies, purchasing groups, the specialist press, or even Tiers-Lieux d'Expérimentation in health.
For information on social and medico-social establishments and services (ESSMS or ESMS), which are structures where professionals welcome and/or support dependent, disabled or socially excluded people, you can consult the G_NIUS page on social and medico-social structures.
G_NIUS is the national hub for innovation and e-health applications, which also supports players in the medical-social sector in the deployment of digital solutions for autonomy, disability, and the elderly.